Home NDC 17312-168-13 Allergy Eyes Relief Nighttime Formula
Product NDC 17312-168
Requested package NDC 17312-168-13
11-digit product format 173120168
Labeler code 17312
Product ID 17312-168_f1ed7811-cdc7-23f4-e053-2a95a90af36b
Type HUMAN OTC DRUG
Nonproprietary name Allium cepa, Ambrosia, Apis, Euphrasia, Histamine hydochloricum, Sabadilla, Sulphur, Valeriana officinalis
Dosage form OINTMENT
Route TOPICAL
Labeler TRP Company
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2019-04-15
Marketing end 0000-00-00
Substance AMBROSIA ARTEMISIIFOLIA; APIS MELLIFERA; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; SCHOENOCAULON OFFICINALE SEED; SULFUR; VALERIAN
Active strength 6 [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g
Pharmacologic classes Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]
NDC exclude flag No
Listing certified through 2024-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 9 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 17312-168 ALLERGY EYES RELIEF NIGHTTIME FORMULA (ALLIUM CEPA, AMBROSIA, APIS, EUPHRASIA, HISTAMINE HYDOCHLORICUM, SABADILLA, SULPHUR, VALERIANA OFFICINALIS) OINTMENT [TRP COMPANY] 4 Legacy NDC 20230111_92daf4d8-04e2-81de-e053-2995a90a26b3.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 17312-168-13 17312016813 1 TUBE in 1 PACKAGE (17312-168-13) > 4 g in 1 TUBE 1 tube 2019-04-15 0000-00-00 No No Current